Boeing And Lockheed: SpaceX Hype Isn't Needed For These Buys

Lockheed Martin and Boeing have not participated in the recent space stock rally, as their space exposure is seen as too limited to drive a meaningful rerating. The article argues ULA's weak cost innovation and poor market fit versus SpaceX reduce competitiveness and limit upside for BA and LMT. Space remains a minority of revenues and profits for both companies, making them less sensitive to space-sector momentum.

Analysis

The market is correctly treating space as an option, not a core earnings driver, for both names. That matters because reratings require either faster growth or a margin re-acceleration, and neither is likely if the addressable space mix remains too small to move consolidated numbers. The second-order implication is that the “space rally” can keep running without forcing a sympathy bid into LMT or BA, especially if capital rotates toward pure-play beneficiaries with cleaner operating leverage.

The bigger risk for BA and, to a lesser extent, LMT is that the competitive gap in launch economics becomes a persistent narrative discount, not just a near-term headwind. If customers and governments increasingly benchmark against SpaceX-level cadence and cost curves, legacy providers may face a slow erosion in bargaining power, lower win rates on new programs, and more pressure to absorb fixed-cost underutilization. That is a multi-quarter to multi-year issue: the market can ignore it for weeks, but valuation multiples usually compress once investors conclude the segment is structurally behind.

Contrarianly, the consensus may be underestimating how little space exposure is needed for either stock to re-rate if the rest of the businesses stabilize. A modest improvement in defense book-to-bill, commercial aerospace execution, or free-cash-flow conversion can dwarf any incremental space contribution. In other words, the bearishness on “missing the space rally” is directionally right but probably overstates the earnings relevance; the better short thesis is not that they lose on space, but that space fails to rescue broader fundamental narratives.

Catalyst-wise, the next 1-3 months are mostly about sentiment and technicals; the fundamental re-rating case is a 6-18 month story tied to contract awards, margin delivery, and whether legacy space offerings can show any cost curve improvement. If that does not happen, the market is likely to keep assigning a persistent conglomerate discount versus more focused aerospace/defense peers.

Key Decisions for Investors

• Avoid buying LMT/BA as a pure momentum proxy for the space rally over the next 1-3 months; the setup offers low beta capture and poor rerating potential versus pure-play space names.
• Use rallies in BA to initiate or add to a tactical short against a basket of space beneficiaries over a 3-6 month horizon; the risk/reward favors BA if investors start pricing in continued competitive underperformance and weak mix translation.
• For LMT, prefer waiting for any drawdown tied to sector rotation before adding long exposure; the better entry is on defense-led weakness, with a 6-12 month thesis anchored in core defense cash generation rather than space optionality.
• Pair trade idea: long a pure-play space beneficiary basket, short BA or LMT, to isolate the valuation gap between credible space leverage and legacy exposure; this should work best if the space rally broadens but legacy names continue to lag on fundamentals.